[Retinal changes--degeneration or side effect caused by etretinate (Tigason) therapy?]
1Univ.-Augenklinik Huddinge, Karolinska Institutet.
Klinische Monatsblatter Fur Augenheilkunde
|March 1, 1989
Summary
This case report details retinal changes observed in a patient undergoing treatment with etretinate (Tigason). It highlights the potential for this medication to cause drug-induced retinopathy.
Area of Science:
- Ophthalmology
- Dermatology
- Pharmacology
Background:
- Etretinate (Tigason) is a systemic retinoid used for severe dermatological conditions.
- Retinoids are known to have various ocular side effects.
Observation:
- A patient treated with etretinate presented with specific retinal changes.
- Detailed clinical and imaging findings of the retinal alterations were documented.
Findings:
- The observed retinal changes were consistent with a potential drug-induced retinopathy.
- Causality between etretinate use and the observed retinopathy is discussed.
Implications:
- This case underscores the importance of ophthalmological monitoring in patients receiving etretinate.
- Awareness of potential etretinate-induced retinopathy is crucial for clinicians.
- Further research may be warranted to elucidate the mechanisms of retinoid-related retinopathy.
